The big trade-off is between computational intensity and the size of the complex.
タンパク質の構造予測に成功したディープマインドのAIコード：その公開の遅れが意味すること
人工知能（AI）研究で世界を牽引するグーグル傘下のディープマインドは、タンパク質の構造予測という生物学の根本的な問題を解決した一方で、学術界の慣行に反してそのニューラルネットワーク「AlphaFold2」のコードをすぐに発表しなかったことで物議を醸すことになった。パンデミックに限らず病原体に対抗する薬の開発にも役立つタンパク質の立体構造をめぐるこの出来事は、AIの情報共有をめぐる学術界と産業界の深刻な課題を浮き彫りにしている。
…
UK class action-style suit filed over DeepMind NHS health data scandal
A U.K. law firm is bringing a class-action style claim over a patient health data scandal that dates back to 2015 and involves the Google-owned AI company DeepMind, after it was quietly passed medical information on more than a million patients by an NHS Trust as part of an app development project. Law firm Mishcon […]
UK dials up the spin on data reform, claiming ‘simplified’ rules will drive ‘responsible’ data sharing
The U.K. government has announced a consultation on plans to shake up the national data protection regime, as it looks at how to diverge from European Union rules following Brexit. It’s also a year since the U.K. published a national data strategy in which said it wanted pandemic levels of data sharing to become Britain’s […]
Google confirms it’s pulling the plug on Streams, its UK clinician support app
Google is infamous for spinning up products and killing them off, often in very short order. It’s an annoying enough habit when it’s stuff like messaging apps and games. But the tech giant’s ambitions stretch into many domains that touch human lives these days. Including, most directly, healthcare. And — it turns out — so […]
AlphaFold2, RoseTTAFold, and the future of structural biology
Back in 2020, we discussed DeepMind’s impressive advances in protein structure prediction, as evinced by their showing at CASP14. They’ve finally made good on their promise to publish their work on AlphaFold2! In the interim, though, David Baker’s gr…
Embodied AI, superintelligence and the master algorithm
In the next year and a half, we’re going to see increasing adoption of technologies, which will trigger a broader industry shift, much as Tesla triggered the transition to EVs.
「顧みられない病気」の治療薬を、DeepMindは人工知能で見つけ出す
アルファベット傘下の人工知能（AI）企業であるDeepMindが、希少な疾患の治療法を見つけるべくAIの活用を加速させている。非営利団体「顧みられない病気の新薬開発イニシアティブ（DNDi）」との提携を通じて、主に途上国で猛威を振るう伝染病などの治療薬候補を見つけ出しているのだ。その先には、新型コロナウイルス感染症（COVID-19）の治療薬の開発も視野に入っている。
…